Kite, a Gilead Company, is a biopharmaceutical company that is dedicated to the development of innovative cancer immunotherapies with a focus on cell-based immunotherapies including chimeric antigen receptor T (CAR T) cell therapy. For more information on Kite, please visit www.kitepharma.com.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California. www.gilead.com.